A5056842764- Transcranial Magnetic Stimulation Studies
- Functional Brain Connectivity Studies
- Pain Management and Treatment
- Vagus Nerve Stimulation Research
- Heart Rate Variability and Autonomic Control
- Neurological disorders and treatments
- Palliative Care and End-of-Life Issues
- Treatment of Major Depression
- Obsessive-Compulsive Spectrum Disorders
- Electroconvulsive Therapy Studies
- Neurology and Historical Studies
- Clinical practice guidelines implementation
- Cancer survivorship and care
- Tryptophan and brain disorders
- Mental Health Research Topics
- Migraine and Headache Studies
- Neuroscience and Neural Engineering
- Neural and Behavioral Psychology Studies
- Genetic Neurodegenerative Diseases
- Patient-Provider Communication in Healthcare
- Digital Mental Health Interventions
- Mind wandering and attention
- Eating Disorders and Behaviors
- Empathy and Medical Education
- Patient Dignity and Privacy
Centre Hospitalier de l’Université de Montréal
2015-2025
TU Dortmund University
2025
Leibniz Research Centre for Working Environment and Human Factors
2025
University of California, San Diego
2025
Centre for Addiction and Mental Health
2025
Université de Montréal
2020-2024
Directorate-General Joint Research Centre
2020
International Neuromodulation Society
2020
HEC Montréal
2020
Université du Québec à Montréal
2015-2018
Vagal neurostimulation (VNS) is used for the treatment of epilepsy and major medical-refractory depression. VNS has neuropsychiatric functions systemic anti-inflammatory activity. The objective this study to measure clinical efficacy impact modulation in depressive patients. Six patients with refractory depression were enrolled. Depression symptoms assessed Montgomery-Asberg Rating, anxiety Hamilton Anxiety Rating Scale. Plasmas harvested prospectively before implantation (baseline) up 4...
This study investigated spaced transcranial direct current stimulation for major depressive disorder, focusing on feasibility.
The Montreal Cognitive Assessment (MoCA) is a general cognitive screening tool that has shown sensitivity in detecting mild levels of impairment various clinical populations. Although mood dysfunction common referrals to memory clinics, the influence on MoCA date been largely unexplored.In this study, we examined impact using clinic sample individuals with depressive symptoms who did not meet criteria for neurodegenerative disease.Half group scored below MoCA-suggested cutoff impairment. As...
Background Treatment-resistant depression (TRD) is a serious chronic condition disabling patients functionally and cognitively. Chronic vagus nerve stimulation (VNS) recognized for the management of TRD, but few studies have examined its long-term effects on cognitive dysfunction in unipolar bipolar resistant depression. Objective The purpose this study was to assess course functions clinical symptoms cohort treated with VNS TRD. Methods In 14 TRD VNS, standardized neuropsychological...
About a third of patients suffering from major depression develop treatment-resistant (TRD). Although repetitive transcranial magnetic stimulation (rTMS) and intravenous ketamine have proven effective for the management TRD, many remain refractory to treatment. We present case patient bipolar TRD. The was referred us after failure respond first-and second-line pharmacotherapy psychotherapy. After minimal response both rTMS alone, we attempted combination protocol, which led complete...
Treatment-resistant depression (TRD) carries a major burden on those affected by this disease and significantly impacts their quality of life (QOL). Vagus nerve stimulation (VNS) has showed promising results symptoms, but its impact QOL remains underresearched. This study aims to evaluate the long-term effects VNS both clinical symptoms for TRD patients, through naturalistic 6-year follow-up.Outpatients with confirmed were enrolled receive VNS. None patients left or was lost at follow-up....
Repetitive transcranial magnetic stimulation (rTMS) is an effective intervention in major depressive disorder (MDD) but requires daily travel to a treatment clinic over several weeks. Shorter rTMS courses retaining similar effectiveness would thus increase the practicality and scalability of technique, therefore its accessibility. We assessed feasibility novel 5 day accelerated 1 Hz protocol. hypothesized that this protocol be safe well-tolerated while shortening overall course. conducted...
On March 11, 2020, the World Health Organization (WHO) declared new coronavirus disease (COVID-19) as a pandemic. This is particularly dangerous for elderly, with older age associated increased morbidity and mortality.1Onder G Rezza Brusaferro S Case-fatality rate characteristics of patients dying in relation to COVID-19 Italy.JAMA. 2020; 323: 1775-1776PubMed Google Scholar To limit its transmission, psychiatric authorities around world have used different strategies transform their...
Medical Assistance in Dying (MAiD) is still considered an evolving practice Canada. Practitioners are facing the challenge of staying up to date and hence need efficient continuing medical education (CME). A patient-partner has been recently invited as a keynote speaker CME activities Canada share her perspectives views about patient engagement palliative care MAiD practice, calling for compassion. To our knowledge, few data exist on patient-partners' contribution these topics. Based that...